Assignee
IOMET PHARMA LTD
GB·9 granted patents·1 pending application·21 citations·filing 2014–2020
Top patents by PatentIndex Score
10 records- 0186US11130738B2Pharmaceutical compoundIOMET PHARMA LTD·Filed 2020·Granted Sep 28, 2021·2 cites·13 claims
- 0285US9931347B2Pharmaceutical compoundIOMET PHARMA LTD·Filed 2014·Granted Apr 3, 2018·6 cites·12 claims
- 0384US10287252B2Inhibitors of tryptophan-2,3-dioxygenase or indoleamine-2,3-dioxygenaseIOMET PHARMA LTD·Filed 2015·Granted May 14, 2019·9 cites·6 claims
- 0481US10590086B2Pharmaceutical compoundIOMET PHARMA LTD·Filed 2015·Granted Mar 17, 2020·3 cites·10 claims
- 0563US10047074B2Pharmaceutical compoundIOMET PHARMA LTD·Filed 2015·Granted Aug 14, 2018·1 cites·11 claims
- 0647US10858319B2Indole derivatives for use in medicineIOMET PHARMA LTD·Filed 2018·Granted Dec 8, 2020·0 cites·7 claims
- 0745US10155972B2Screening methodIOMET PHARMA LTD·Filed 2014·Granted Dec 18, 2018·0 cites·20 claims
- 0843US11096930B2Substituted imidazopyridine compounds as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan-2,3-dioxygenaseIOMET PHARMA LTD·Filed 2017·Granted Aug 24, 2021·0 cites·14 claims
- 0940US2016120863A1Slc2a transporter inhibitorsIOMET PHARMA LTD·Filed 2014·Application pending·0 cites
- 1032US10167257B2Indole derivatives for use in medicineIOMET PHARMA LTD·Filed 2015·Granted Jan 1, 2019·0 cites·24 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →